Novel marker may help diagnose aggressive cancers with poor prognosis

cancer

A study published in The Journal of Pathology reveals that many cancers that carry a poor prognosis express an altered form of human telomerase reverse transcriptase (hTERT), an enzyme that regulates the expression of multiple genes.

Scientists previously linked a modification called phosphorylation at a particular location on the hTERT enzyme to poor prognosis in liver and pancreatic cancers. Now the team has built on this research to show that elevated levels of this phosphorylated hTERT are common in other types of cancer as well, especially when the cancers have aggressive features.

Source: Read Full Article

Related posts:
  1. Girl, two, saves her mother’s life using FACETIME
  2. Costs, Expected Weight Loss Impact Bariatric Surgery Choice
  3. High blood pressure: This salt ‘substitute’ may lower your bp reading reveals study
  4. Coronavirus: Health officials urge vigilance as countries ease lockdowns
  5. Children’s Book Could Help Catch Color Vision Deficiency